Impact of Tenofovir on Hepatitis Delta Virus Replication in the Swiss Human Immunodeficiency Virus Cohort Study.

Details

Request a copyRequest a copy
Serval ID
serval:BIB_BA76B0AD3D71
Type
Article: article from journal or magazin.
Collection
Publications
Institution
UNIL/CHUV
Title
Impact of Tenofovir on Hepatitis Delta Virus Replication in the Swiss Human Immunodeficiency Virus Cohort Study.
Journal
Clinical infectious diseases
Author(s)
Béguelin C., Friolet N., Moradpour D., Sahli R., Suter-Riniker F., Lüthi A., Cavassini M., Günthard H.F., Battegay M., Bernasconi E., Schmid P., Calmy A., Atkinson A., Rauch A., Wandeler G.
Working group(s)
Swiss HIV Cohort Study
ISSN
1537-6591 (Electronic)
ISSN-L
1058-4838
Publication state
Published
Issued date
01/05/2017
Peer-reviewed
Oui
Volume
64
Number
9
Pages
1275-1278
Language
english
Notes
Publication types: Journal Article
Publication Status: ppublish
Abstract
We analyzed changes in hepatitis B virus and hepatitis delta virus (HDV) viral loads (VL) during tenofovir-containing antiretroviral therapy among patients with a replicating HDV infection in the Swiss HIV Cohort Study. Only 28.6% experienced a ≥2.0 log reduction in HDV RNA, and 14.3% had undetectable HDV VL within 5 years.

Keywords
Adult, Anti-HIV Agents/therapeutic use, Cohort Studies, Female, HIV Infections/complications, HIV Infections/drug therapy, Hepatitis B virus/isolation & purification, Hepatitis B, Chronic/complications, Hepatitis B, Chronic/virology, Hepatitis D/virology, Hepatitis Delta Virus/drug effects, Hepatitis Delta Virus/isolation & purification, Hepatitis Delta Virus/physiology, Humans, Male, Middle Aged, Switzerland, Tenofovir/therapeutic use, Viral Load, Virus Replication/drug effects, coinfection, hepatitis delta virus, human immunodeficiency virus, replication, tenofovir
OAI-PMH
oai:serval.unil.ch:BIB_BA76B0AD3D71
DOI
10.1093/cid/cix125
Pubmed
28199492
Web of science
000399377100020
Create date
21/02/2017 18:58
Last modification date
20/08/2019 16:28
Usage data